Catalyst Wire Dossier Catalyst Wire Dossier

Optivate

von Willebrand factor concentrate (plasma-derived) · Bio Products Laboratory
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Optivate, covering 2010-03-03 to 2021-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A [Phase 4]

See pricing